Skip to content
Paragon Biosciences LLC
  • About Us
  • Our Approach
  • Portfolio
  • Leadership
  • Careers
  • Contact Us
  • News Room

2023

12 items

  • February 21, 2023

    Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates

    WAKIX® (pitolisant) Net Revenue Increased ~41% Year-over-Year [...]

  • January 12, 2023

    Evozyne Creates AI Model with NVIDIA for Novel Protein Design, Expected to Accelerate Drug Development

    – New AI model, co-developed by Evozyne [...]

  • January 11, 2023

    Emalex Biosciences Publishes Phase 2b Results for Tourette Syndrome Candidate in Pediatrics

    – Study data shows investigational new drug, [...]

  • January 11, 2023

    Veteran Technology Executive Mike Gamson Named Evozyne CEO

    – Gamson to set commercial direction, strengthen [...]

Previous12

© 2026 Paragon Biosciences LLC | Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500, Chicago, IL 60611 |

© 2026 Paragon Biosciences LLC | Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500, Chicago, IL 60611

© 2026 Paragon Biosciences LLC
Privacy Policy | Terms of Use

330 N Wabash Avenue, Suite 3500
Chicago, IL 60611

Page load link
Go to Top